Ludocare: smart health connected companions to improve children’s compliance

[ad_1]

The Lyon start-up Ludocare offers digital therapies that improve the health of children with chronic or rare diseases. Discovery.

Patients with chronic (such as asthma) or rare (such as cystic fibrosis) diseases do not take their treatment or take it poorly, in particular because of their complexity and heaviness on a daily basis. This lack of compliance has serious consequences such as the deterioration of the state of health and quality of life of patients, as well as major additional costs for the health system. Therapeutic education – which makes the patient more independent and facilitates adherence to treatments – must be done from an early age. Indeed, an observant child will be a future observant adult with a better quality of life.

To respond to this challenge, the Lyon startup Ludocare offers digital therapies at the service of patients, their entourage and healthcare professionals. These DTx are materialized by smart health connected robots to guide young children in taking their treatments: Joe and Léo.

Ludocare’s mission is to improve the health of children by allowing them to become autonomous in the management of their treatment. The companions developed aim to stabilize the basic treatment and control the disease for an improvement in the state of health and quality of life in the long term.

Parental involvement is important for good observance, but it is ambivalent, because it is both expected and rejected, even a source of conflict. We often observe a rejection on the part of the child who undergoes the treatment as a constraint and an injunction from the parents. The deterioration of the parent-child relationship linked to taking medication promotes poor compliance.

Because compliance is above all a question of education and empowerment, Ludocare has chosen to support children aged 3 to 11, with a particular focus on asthma, the first chronic disease in children. .

The digital therapies developed come in addition to drug treatment. They aim to improve the efficiency of treatments through personalized support that empowers the child, by acting on therapeutic compliance at two levels:

• quantitative adherence, by influencing the child’s daily behavior and allowing him to integrate his treatment into a routine

• qualitative compliance, by guiding the child in the right actions to avoid misuse and maximize the effectiveness of drugs

Available since September 2019, the digital therapies developed by Ludocare provide a solution to the problem of non-compliance, as demonstrated by the results observed in 223 families after 1 year of using the solution:

Joe and Léo: smart health connected companions for good compliance

Joe and Léo are the two robots created by Ludocare. Marked as medical devices, they improve the health of child-patients aged 3 to 11 on a daily basis, as well as that of those around them. Joe is the specialist in chronic diseases (asthma), while Léo is dedicated to rare diseases (cystic fibrosis).

Joe and Léo accompany the children in the correct technique of taking their treatments, thus allowing better control of the disease. The child gains autonomy and self-confidence. When taking medication, the robot rings and calls the child. Then he guides him step by step by stating the name of the drugs and their dosage as well as by showing the right actions to be done by means of animations on the screen.

Joe and Léo motivate the child by unlocking daily multimedia rewards (song, story, game…) personalized, thanks to a learning algorithm. True everyday companion, the robot interacts with the child (cuddling, tickling, waking up, going to bed, etc.).

To support parents, a mobile application is associated with the robots to allow the planning of treatment taken by directly scanning the barcodes of the drugs. All the drugs available in France are listed there. The taking methods are fully customizable: all you have to do is enter the dosage and indicate the times of taking. The mobile application also offers simple calendar management, such as medical appointments. Informed of the robot’s activity thanks to real-time notifications, parents are reassured. Finally, the issuance of monthly medical reports allows effective follow-up during appointments with the doctor.

” One of the pillars of our strategy is to demonstrate the clinical benefit of our digital therapies. For this, a Ludocare clinical study will see the light of day in 2021, with the long-term objective of allowing health insurance coverage. Today, we are already delighted that families have been able to obtain reimbursement for all or part of our medical service through their mutual, but we want to go even further! At the same time, we are focusing on fundraising in series A, which will allow Ludocare to become the benchmark player in digital therapies dedicated to pediatrics. A new stage in our development, which we are delighted to build alongside ambitious partners! The future is in digital therapies. There are still major challenges to be taken up in this market and it is together – startups, health professionals and authorities, patients, pharmaceutical industry – that we will do it.. »Says Alexandra de la Fontaine, CEO of Ludocare.

A scientific council, made up of specialists in childhood asthma, biostatisticians and methodologists, supports Ludocare in the strategy and drafting of the clinical protocol.

The solutions made in France are CE marked as a medical device and comply with the GDPR. They meet the standards for the management of health data collected and secured by a certified host in France.

Source: Ludocare

Similar articles

[ad_2]